Trial intelligence / Profile preview

Metformin Glycinate vs Metformin Hydrochloride in T2D

NCT04943692Phase 3Suspended

Sponsor
Laboratorios Silanes
Start
Aug 2021
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Metformin glycinate in type 2 diabetes mellitus (T2DM), sponsored by Laboratorios Silanes. Started Aug 2021; status: suspended.

02

Drugs

Metformin glycinate
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT04943692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04943692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call